Panelists discuss how biomarker testing is currently utilized in the management of patients with small cell lung cancer (SCLC), including its timing within the treatment journey, while also exploring ...
News Medical on MSN6d
Harnessing neural networks to forecast treatment outcomes in small cell lung cancerAs immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes has become a focal point in clinical practice. Immunotherapy combined with ...
The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell ...
Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as ...
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune ...
Ticiana Leal, MD, discusses how in cases of extensive stage small cell lung cancer (ES-SCLC) that progress within 6 months of ...
There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...
In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...
First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback